Zensun Sci &
Tech, Ltd., a
biopharmaceutical
company based in
Shanghai and San
Diego, announced
today positive
results of four
completed Phase 2
c
(
more)
Zensun Sci & Tech, Ltd., a biopharmaceutical company based in Shanghai and San Diego, announced today positive results of four completed Phase 2 clinical trials including three double-blind, placebo-controlled studies conducted in China and Australia and interim results from the United States Phase 2 trial for Zensun’s innovative “first-in-class†anti-heart failure drug, Neucardin™.
To view Multimedia News Release, go to
http://www.multivu.com/mnr/616...Originally collected by
fetching...
(
less)